Long‐Term Effects of Novel Combination Coating Anti‐CD34 Antibody Applied on Sirolimus‐Eluting Stents

E-ISSN： 1540-8183|28|3|257-263

ISSN： 0896-4327

Source： JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol.28, Iss.3, 2015-06, pp. : 257-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre‐transplant antibody screening and anti‐CD154 costimulation blockade promote long‐term xenograft survival in a pig‐to‐primate kidney transplant model

XENOTRANSPLANTATION (ELECTRONIC), Vol. 22, Iss. 3, 2015-05 ,pp. : 221-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term safety of drug-eluting stents in patients on warfarin treatment

By Annala Antti-Pekka Karjalainen Pasi P. Biancari Fausto Niemelä Matti Ylitalo Antti Vikman Saila Porela Pekka Airaksinen K. E. Juhani

Annals of Medicine, Vol. 44, Iss. 3, 2012-05 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

Stent Thrombosis with Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents: An Update Meta-Analysis

Cardiology, Vol. 130, Iss. 2, 2015-01 ,pp. : 96-105

Karger

Access to resources Recommend Favorite

The Supralimus ® sirolimus-eluting stent

By Lemos Pedro A Bienert Igor

Expert Review of Medical Devices, Vol. 10, Iss. 3, 2013-05 ,pp. : 295-300

Informa Healthcare

Access to resources Recommend Favorite

The combination of milatuzumab, a humanized anti‐CD74 antibody, and veltuzumab, a humanized anti‐CD20 antibody, demonstrates activity in patients with relapsed and refractory B‐cell non‐Hodgkin lymphoma

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 701-710

John Wiley & Sons Inc

Access to resources Recommend Favorite